on Lir Life Sciences Corp. (CVE:SKNY)
LIR Life Sciences Appoints Dr. Peter Singer as Scientific Advisor
LIR Life Sciences Corp. has announced the appointment of Dr. Peter Singer as a Scientific Advisor. Dr. Singer is recognized for his expertise in global health, having previously served as Special Advisor to the Director General of the World Health Organization. He brings over 25 years of leadership in health innovation and policy.
Dr. Singer's past roles include CEO of Grand Challenges Canada, where he managed over CAD $450 million in funding for health innovations worldwide. His academic accomplishments include serving as Professor of Medicine Emeritus at the University of Toronto.
At LIR, Dr. Singer will contribute to strategies for expanding obesity treatment access globally. His deep understanding of health systems and policy is expected to support LIR in offering scalable, practical solutions to the obesity epidemic.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Lir Life Sciences Corp. news